Cell/Gene Therapies’ Unique Attributes Set Them Apart, Say Comments on Draft Guidance

Comments filed on the FDA’s proposed guidance on potency assurance for cellular and gene therapy (CGT) products reflect the intricacies that set these treatments apart from drug interventions.
Source: Drug Industry Daily